Finance

Beta
Lists
0950:HKG
Lee's Pharmaceutical Holdings Ltd
HK$1.09
0.00%
(0.00) 1D
Jun 11, 1:25:16 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0950...
Open
HK$1.05
High
HK$1.10
Low
HK$1.04
Mkt. cap
641.83M
Avg. vol.
800.65K
Volume
530.50K
Dividend
4.13%
Quarterly dividend
HK$0.01
Ex-dividend date
May 27, 2026
P/E ratio
6.98
52-wk high
HK$2.70
52-wk low
HK$0.99
EPS
HK$0.16
Shares outstanding
592.03M
No. of employees
1K
Open
HK$1.05
High
HK$1.10
Low
HK$1.04
Mkt. cap
641.83M
Avg. vol.
800.65K
Volume
530.50K
Dividend
4.13%
Quarterly dividend
HK$0.01
Ex-dividend date
May 27, 2026
P/E ratio
6.98
52-wk high
HK$2.70
52-wk low
HK$0.99
EPS
HK$0.16
Shares outstanding
592.03M
No. of employees
1K
News stories
From sources across the web
About Lee's Pharmaceutical Holdings Ltd
CEO-
Employees1.09K
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
347.41M
347.41M
370.58M
370.58M
Cost of goods sold
167.38M
167.38M
185.83M
185.83M
Cost of revenue
167.38M
167.38M
185.83M
185.83M
Research and development expenses
20.81M
20.81M
34.67M
34.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
127.09M
127.09M
151.39M
151.39M
Operating expense
146.84M
146.84M
162.80M
162.80M
Total operating expenses
314.22M
314.22M
348.63M
348.63M
Operating income
33.19M
33.19M
21.95M
21.95M
Other non operating income
-117.50K
-117.50K
-71.00K
-71.00K
EBT including unusual items
30.34M
30.34M
6.11M
6.11M
EBT excluding unusual items
30.34M
30.34M
14.29M
14.29M
Income tax expense
5.06M
5.06M
6.07M
6.07M
Effective tax rate
16.69%
16.69%
99.43%
99.43%
Other operating expenses
-1.30M
-1.30M
-23.11M
-23.11M
Net income
33.59M
33.59M
12.38M
12.38M
Net profit margin
9.67%
9.67%
3.34%
3.34%
Earnings per share
-
-
-
-
Interest and investment income
567.00K
567.00K
367.00K
367.00K
Interest expense
-3.06M
-3.06M
-2.37M
-2.37M
Net interest expenses
-2.49M
-2.49M
-2.00M
-2.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
69.27M
69.27M
29.76M
29.76M
Gain or loss from assets sale
-
-
99.00K
99.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more